Literature DB >> 18389335

The mild form of mucopolysaccharidosis type I (Scheie syndrome) is associated with increased ascending aortic stiffness.

Attila Nemes1, Remco G M Timmermans, J H Paul Wilson, Osama I I Soliman, Boudewijn J Krenning, Folkert J ten Cate, Marcel L Geleijnse.   

Abstract

Mucopolysaccharidosis type I (MPS IS) is a rare autosomal recessive disease caused by a deficiency of the lysosomal enzyme alpha-L-iduronidase, which is involved in the degradation of sulfated glycosaminoglycans (GAGs). The deficiency results in the intra-and pericellular accumulation of the GAGs heparan sulfate and dermatan sulfate. Eight adult patients with typical features of MPS IS aged 31.5 +/- 6.8 years (five men) were included and compared to age-and gender-matched controls. With transthoracic echocardiography, cyclic ascending aortic diameter changes were measured and ascending aortic elastic properties were calculated to characterize aortic elasticity. In MPS IS patients, aortic stiffness index was significantly increased (23.1 +/- 10.4 vs 3.9 +/- 1.5, P < 0.001), while aortic distensibility was significantly decreased (1.6 +/- 0.8 vs 4.6 [corrected] +/- 1.9 cm(2)/dynes [corrected] 10(-6), P < 0.001) compared to age-and sex-matched controls. The results of the present study demonstrate that in addition to the known cardiac complications, MPS IS patients have an impairment of ascending aortic elasticity. Further follow-up studies are needed to examine arterial elasticity using other methods in this patient population, and to detect possible effects of enzyme replacement therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18389335     DOI: 10.1007/s00380-007-1013-x

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  15 in total

1.  Light and electron microscopy of the cornea in systemic mucopolysaccharidosis type I-S (Scheie's syndrome).

Authors:  V Rummelt; H J Meyer; G O Naumann
Journal:  Cornea       Date:  1992-01       Impact factor: 2.651

2.  Evaluation of coronary artery disease in the Hurler syndrome by angiography.

Authors:  E A Braunlin; D W Hunter; W Krivit; B A Burke; P S Hesslein; P T Porter; C B Whitley
Journal:  Am J Cardiol       Date:  1992-06-01       Impact factor: 2.778

3.  Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome.

Authors:  Elizabeth Braunlin; Shannon Mackey-Bojack; Angela Panoskaltsis-Mortari; James M Berry; Ron T McElmurry; Megan Riddle; Li-Yan Sun; Lorne A Clarke; Jakub Tolar; Bruce R Blazar
Journal:  Pediatr Res       Date:  2005-12-02       Impact factor: 3.756

4.  Structural abnormalities in the dermal collagen and elastic matrix from the skin of patients with inherited connective tissue disorders.

Authors:  K A Holbrook; P H Byers
Journal:  J Invest Dermatol       Date:  1982-07       Impact factor: 8.551

5.  Increased aortic stiffness in glycogenosis type 2 (Pompe's disease).

Authors:  Attila Nemes; Osama I I Soliman; Marcel L Geleijnse; Ashraf M Anwar; Nadine A M E van der Beek; Pieter A van Doorn; Henriette Gavallér; Eva Csajbók; Folkert J ten Cate
Journal:  Int J Cardiol       Date:  2006-11-03       Impact factor: 4.164

6.  Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I.

Authors:  Elizabeth A Braunlin; James M Berry; Chester B Whitley
Journal:  Am J Cardiol       Date:  2006-06-12       Impact factor: 2.778

Review 7.  Laronidase treatment of mucopolysaccharidosis I.

Authors:  Ed J Wraith; John J Hopwood; Maria Fuller; Peter J Meikle; Doug A Brooks
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

8.  The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases.

Authors:  V G Rentería; V J Ferrans; W C Roberts
Journal:  Am J Cardiol       Date:  1976-10       Impact factor: 2.778

9.  Arteriopathy and coarctation of the abdominal aorta in children with mucopolysaccharidosis: imaging findings.

Authors:  D B Taylor; S I Blaser; P E Burrows; D A Stringer; J T Clarke; P Thorner
Journal:  AJR Am J Roentgenol       Date:  1991-10       Impact factor: 3.959

10.  Aortic elastic properties and left ventricular diastolic dysfunction in patients with obstructive sleep apnea.

Authors:  Hulya Akhan Kasikcioglu; Levent Karasulu; Ebru Durgun; Huseyin Oflaz; Erdem Kasikcioglu; Caglar Cuhadaroglu
Journal:  Heart Vessels       Date:  2005-11       Impact factor: 1.814

View more
  13 in total

1.  Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation.

Authors:  Guilherme Baldo; Susan Wu; Ruth A Howe; Meera Ramamoothy; Russell H Knutsen; Jiali Fang; Robert P Mecham; Yuli Liu; Xiaobo Wu; John P Atkinson; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2011-08-24       Impact factor: 4.797

2.  Long-term nonsense suppression therapy moderates MPS I-H disease progression.

Authors:  Gwen Gunn; Yanying Dai; Ming Du; Valery Belakhov; Jeyakumar Kandasamy; Trenton R Schoeb; Timor Baasov; David M Bedwell; Kim M Keeling
Journal:  Mol Genet Metab       Date:  2013-12-17       Impact factor: 4.797

3.  Endothelial function in children and adolescents with mucopolysaccharidosis.

Authors:  Aaron S Kelly; Andrea M Metzig; Julia Steinberger; Elizabeth A Braunlin
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

4.  Chronic intrauterine hypoxia interferes with aortic development in the late gestation ovine fetus.

Authors:  Jennifer A Thompson; Bryan S Richardson; Robert Gagnon; Timothy R H Regnault
Journal:  J Physiol       Date:  2011-05-03       Impact factor: 5.182

5.  Wave intensity wall analysis: a novel noninvasive method to measure wave intensity.

Authors:  Matilda Larsson; Anna Bjällmark; Britta Lind; Rita Balzano; Michael Peolsson; Reidar Winter; Lars-Ake Brodin
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

6.  A self-inactivating gamma-retroviral vector reduces manifestations of mucopolysaccharidosis I in mice.

Authors:  Jason A Metcalf; Xiucui Ma; Bruce Linders; Susan Wu; Axel Schambach; Kevin K Ohlemiller; Attila Kovacs; Mark Bigg; Li He; Douglas M Tollefsen; Katherine P Ponder
Journal:  Mol Ther       Date:  2009-10-20       Impact factor: 11.454

7.  Vascular biomechanical properties in mice with smooth muscle specific deletion of Ndst1.

Authors:  Neeta Adhikari; Marie Billaud; Marjorie Carlson; Spencer P Lake; Kim Ramil C Montaniel; Rod Staggs; Weihua Guan; Dinesha Walek; Snider Desir; Brant E Isakson; Victor H Barocas; Jennifer L Hall
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

8.  Carotid intima-media thickness is increased in patients with treated mucopolysaccharidosis types I and II, and correlates with arterial stiffness.

Authors:  Raymond Y Wang; Elizabeth A Braunlin; Kyle D Rudser; Donald R Dengel; Andrea M Metzig; Kelly K Covault; Lynda E Polgreen; Elsa Shapiro; Julia Steinberger; Aaron S Kelly
Journal:  Mol Genet Metab       Date:  2013-11-12       Impact factor: 4.797

9.  Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.

Authors:  Jason A Metcalf; Bruce Linders; Susan Wu; Paul Bigg; Patricia O'Donnell; Meg M Sleeper; Michael P Whyte; Mark Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

Review 10.  Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.

Authors:  Elizabeth A Braunlin; Paul R Harmatz; Maurizio Scarpa; Beatriz Furlanetto; Christoph Kampmann; James P Loehr; Katherine P Ponder; William C Roberts; Howard M Rosenfeld; Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2011-07-09       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.